feedback welcome

Citalopram-tranylcypromine

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][draft revision]
 
Line 3: Line 3:
| to = tranylcypromine
| to = tranylcypromine
| stop =  
| stop =  
-
{{stopCitalopram14d}}
+
{{generaldecrease25p3d}}
 +
{{14dwashout}}
| start =  
| start =  
-
* '''Day 15-29:''' a wash-out period of two weeks is safe even in liver malfunction and in the elderly.
+
*a wash-out period of two weeks is safe even in liver malfunction and in the elderly.
-
* '''Day 30:''' Start administration of tranylcypromine in low dosage of 20 mg/day for one week.
+
{{Starttranyl}}
-
* '''Day 37:''' after this week the dosage of tranylcypromine can be increased if necessary.
+
| caveat =  
| caveat =  
* Occurrence of serotonin syndrome is reported when a wash-out period (of one week) is not considered.  
* Occurrence of serotonin syndrome is reported when a wash-out period (of one week) is not considered.  
{{SSRI14d}}
{{SSRI14d}}
}}
}}

Current revision as of 11:29, 20 June 2016

Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram
Tranylcypromine
Type Antidepressant
Group MAO-I
links
Medscape Tranylcypromine
PubChem 5530
PubMed Tranylcypromine
Wikipedia Tranylcypromine

Switch medication from citalopram to tranylcypromine.

Nietinrijdenbord.png Stop citalopram
Eenrichtingbord.png Start tranylcypromine
Letopbord.png Cave


The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About